Global  

China gets 'promising' early results from COVID-19 vaccine trial

USATODAY.com Friday, 22 May 2020 ()
Within two weeks of getting the vaccine, some developed so-called neutralizing antibodies, which can kill SARS-CoV-2, the virus that causes COVID-19.
0
shares
ShareTweetSavePostSend
 
Video credit: Reuters Studio - Published
News video: AstraZeneca to make billion COVID vaccine doses if tests succeed

AstraZeneca to make billion COVID vaccine doses if tests succeed 01:20

AstraZeneca expects to be able to deliver a billion doses of a possible COVID-19 vaccine this year and next if tests are successful, adding on Thursday it should shortly get results of an early stage clinical trial. Ciara Lee reports

Related videos from verified sources

Stool Tests May Help Spot COVID-19 Transmission [Video]

Stool Tests May Help Spot COVID-19 Transmission

ZHUHAI, CHINA — Health authorities might be able to detect COVID-19's spread by testing the sewers of a community for the coronavirus's RNA. Citing a new study in Gastroenterology, British..

Credit: TomoNews US     Duration: 01:27Published
Coronavirus Vaccine From China Is Safe In Early Trial [Video]

Coronavirus Vaccine From China Is Safe In Early Trial

A coronavirus vaccine developed by CanSino Biologics Inc appears to be safe. It induced a rapid immune response in its first human trial, Reuters reports. This vaccine did not cause any serious adverse..

Credit: Wochit Business     Duration: 00:39Published

Related news from verified sources

Covid vaccine shows promising early results in China

The trial is the first step in testing the vaccine and was intended mainly to verify its safety. Proof of its effectiveness will require trials in thousands,...
IndiaTimes

Early results from Moderna vaccine trial show participants developed antibodies against coronavirus

Study subjects who received Moderna's COVID-19 vaccine had positive early results, according to the biotech company, which partnered with the National Institutes...
CTV News


Tweets about this